Acquisition Proven MSD was acquired by McKesson in 2018 for $800M, indicating strong market relevance and potential for leveraging a broader distribution network and enterprise capabilities to expand product reach and co selling opportunities.

Post-Acute Focus Specializes in home infusion, home medical equipment, and oncology markets, suggesting sales opportunities across infusion therapies, patient home care equipment, and oncology support services with bundled solutions and long-term contracts.

Portfolio Synergy Owns brands like First Choice Medical Supply and Attentus Medical Sales, enabling cross-sell of medical devices, rental programs, biomedical maintenance, and technology solutions to existing MSD customers and new prospects.

Tech-Driven Ops Utilizes a technology driven operational footprint and outsourced services with a modern tech stack, creating opportunities to upsell digital patient engagement tools, device management platforms, and data-driven analytics services.

Growth Signals Recent acquisitions and partnerships with Mediware and VerbalCare history signal a trend toward integrated systems and patient communication solutions, indicating openings for turnkey post-acute care platforms and interoperability services.